| Document Date: 2013-09-18 04:51:43
Open Document File Size: 159,58 KBShare Result on Facebook
City Marlborough / Epilepsy Mississauga / Mississauga / / Company Dainippon Sumitomo Pharma Co. Ltd. / Sumitomo Pharmaceuticals Co. Ltd. / Dainippon Pharmaceutical Co. Ltd. / BIAL-Portela & C S.A. / Douglas Reynolds President Sunovion Pharmaceuticals Canada Inc. / Sunovion Pharmaceuticals Canada Inc. / Sunovion Pharmaceuticals Inc. / / Country Japan / United States / Canada / / / Event M&A / / IndustryTerm prescription products / pharmaceutical products / pharmaceutical / treatment option / food / / MedicalCondition ataxia / partial-onset seizures / onset seizures / headache / standardized seizure / nausea / vertigo / cardiovascular disease / vomiting / common neurological disorders / fatigue / better managing partial-onset seizures / epilepsy / Partialonset Seizures / Adequate seizure / dizziness / recurrent seizures / diplopia / infectious disease / / MedicalTreatment adjunctive therapy / / Person Patricia Moriarty / / / Position President / Director / / Product Sunovion Pharmaceuticals 6790 Century Ave / / ProvinceOrState Massachusetts / Ontario / / URL www.ds-pharma.com / www.sunovion.ca / http /
SocialTag |
Sunovion Pharmaceuticals Canada Inc. Sunovion Pharmaceuticals 6790 Century Ave., Suite 100Inc.